Is more of a good thing still a good thing? PARP inhibitor retreatment in high-grade ovarian carcinoma

被引：0
|
作者：
McNeish, I. A. [1 ]
Monk, B. J. [2 ]
机构：
[1] Imperial Coll London, Ovarian Canc Act Res Ctr, Dept Surg & Canc, London, England
[2] Univ Arizona, HonorHlth Res Inst, Coll Med, Div Gynecol Oncol, Phoenix, AZ USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷 / 12期
关键词：
OLAPARIB MAINTENANCE THERAPY; DOUBLE-BLIND; OPEN-LABEL; CANCER; RUCAPARIB; PHASE-2; RESISTANCE; MULTICENTER; MUTATIONS;
D O I：
10.1016/j.annonc.2023.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1074 / 1076
页数：3
相关论文
共 50 条
  • [41] Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
    Kondrashova, Olga
    Nguyen, Minh
    Shield-Artin, Kristy
    Tinker, Anna V.
    Teng, Nelson N. H.
    Harrell, Maria I.
    Kuiper, Michael J.
    Ho, Gwo-Yaw
    Barker, Holly
    Jasin, Maria
    Prakash, Rohit
    Kass, Elizabeth M.
    Sullivan, Meghan R.
    Brunette, Gregory J.
    Bernstein, Kara A.
    Coleman, Robert L.
    Floquet, Anne
    Friedlander, Michael
    Kichenadasse, Ganessan
    O'Malley, David M.
    Oza, Amit
    Sun, James
    Robillard, Liliane
    Maloney, Lara
    Bowtell, David
    Giordano, Heidi
    Wakefield, Matthew J.
    Kaufmann, Scott H.
    Simmons, Andrew D.
    Harding, Thomas C.
    Raponi, Mitch
    McNeish, Iain A.
    Swisher, Elizabeth M.
    Lin, Kevin K.
    Scott, Clare L.
    CANCER DISCOVERY, 2017, 7 (09) : 984 - 998
  • [42] A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
    Tinker, Anna, V
    Altman, Alon D.
    Bernardini, Marcus Q.
    Ghatage, Prafull
    Gien, Lilian T.
    Provencher, Diane
    Salvador, Shannon
    Doucette, Sarah
    Oza, Amit M.
    CURRENT ONCOLOGY, 2022, 29 (06) : 4354 - 4369
  • [43] Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma
    Pugh-Toole, Morgan
    Nicolela, Anna P.
    Nersesian, Sarah
    Leung, Brendan M.
    Boudreau, Jeanette E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (02) : 210 - 226
  • [44] Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
    Hwangbo, Suhyun
    Kim, Se Ik
    Kim, Ju-Hyun
    Eoh, Kyung Jin
    Lee, Chanhee
    Kim, Young Tae
    Suh, Dae-Shik
    Park, Taesung
    Song, Yong Sang
    CANCERS, 2021, 13 (08)
  • [45] "In good spirits" after getting a diagnosis of cancer: a study of patients with high-grade glioma
    Marcoux, I.
    PSYCHO-ONCOLOGIE, 2012, 6 (04) : 209 - 216
  • [46] PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
    Dickson, Kristie-Ann
    Xie, Tao
    Evenhuis, Christian
    Ma, Yue
    Marsh, Deborah J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [47] Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
    Jia, Yaxun
    Wang, Min
    Sang, Xiaolin
    Liu, Pixu
    Gao, Jingchun
    Jiang, Kui
    Cheng, Hailing
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [48] Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma
    Zelisse, Hein S.
    Hwan, Robin A.
    van de Vijver, Marc J.
    Dijk, Frederike
    Mom, Constantijne H.
    Hooijer, Gerrit K. J.
    van Gent, Mignon D. J. M.
    Snijders, Malou L. H.
    VIRCHOWS ARCHIV, 2024, 486 (2) : 381 - 391
  • [49] PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
    Spear, Sarah
    Le Saux, Olivia
    Mirza, Hasan B.
    Iyer, Nayana
    Tyson, Katie
    Freile, Fabio Grundland
    Walton, Josephine B.
    Woodman, Chloe
    Jarvis, Sheba
    Ennis, Darren P.
    Hernandez, Carmen Aguirre
    Xu, Yuewei
    Spiliopoulou, Pavlina
    Brenton, James D.
    Costa-Pereira, Ana P.
    Cook, David P.
    Vanderhyden, Barbara C.
    Keun, Hector C.
    Triantafyllou, Evangelos
    Arnold, James N.
    Mcneish, Iain A.
    CANCER RESEARCH, 2024, 84 (22) : 3772 - 3787
  • [50] Differential expression of immune related genes in high-grade ovarian serous carcinoma
    Siamakpour-Reihani, Sharareh
    Cobb, Lauren Patterson
    Jiang, Chen
    Zhang, Dadong
    Previs, Rebecca A.
    Owzar, Kouros
    Nixon, Andrew B.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 662 - 668
12345